SNDX Syndax Pharmaceuticals, Inc.
$19.05▼ -2.95%
Unknown
Other
Last sync: just now
Syncing
Key Metrics & Fundamentals
Market Cap
$1.69B
P/E Ratio
–
Div Yield
–%
52W Range
9.49 - 25.59
% vs 50 MA
-3.96%
% vs 200 MA
-3.34%
RSI-14
37.8
MACD Histogram
-0.4900
Beta (1Y vs SPY)
0.60
Gross Rev
$217.17M
Gross Profit
-$50.33M
EBITDA
-$223.77M
COGS
$267.50M
Operating Exp
$173.44M
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Volume (M)
Financial Overview - Income Statement
Quarterly
Jun 2026 (Quarterly)
Social Sentiment
Avg +0.70 · 2 posts
DDPriceTargetDiscussionSyndax Pharmaceuticals a promising commercial biotech with multiple approved drugs - Price target $20-56 (M&A possible)
r/wallstreetbets · Nov 9, 2025
The author is actively invested and expresses a bullish outlook, highlighting commercial products and a large cash balance.
positive
+0.80
NewsTradeDDSNDX straddle
r/wallstreetbets · Aug 28, 2024
The discussion around a potential FDA approval suggests optimism regarding the stock's future.
positive
+0.60
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not Financial Advice.
All data, scores, charts, and analysis on this site are provided for informational and educational purposes only
and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
Always consult a qualified financial advisor before making any investment decisions.
See our Legal Notice for full details.